It has been reported that deregulation of leptin production or availability during pregnancy could alter foetal growth through inappropriate placental development and function and program offspring to a higher risk of developing metabolic diseases, such as obesity [5,6,7]. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.